RE:Commentary...on today's trading...The share price Spectral trades at has nothing to do with it's actual value. MM - we have gone through the analysis separately and come to the conclusion it's worth around $9 per share. Paradigm has put a value at about half that amount almost 2 years ago. For the current price of $0.30 or so SAMI and DIMI would have to be worth nothing (hard to imagine as significant FDA approvals in place) and the PMX would also have to be worth nothing (hard to imagine given its acceptance in large parts of the world). The EAA approved test would likely be sufficient on its own to justify $0.30 per share.
So we have a big disconnect between real value and trading value. As has been pointed out many times on this board "they own it all". So "they" are selecting these artificially low trading prices for their own purpose(s) obviously unknown to shareholders here. Insiders have been buying at much higher prices relative to current trading prices and not disposing of any shares. That provides significant comfort in and of itself.
It does look like the target is $0.30 based on the 47,500 bid amount currently on display. Based on volume it doesn't look like "they" are looking to drag it down further. I agree with others that we are very close to news on the Dialco side and the PMX side and when that comes the share price should start to reflect real value. Too many large players with an interest in the Spectral "ponies" for the value to be suppressed much longer.